These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 235822)

  • 1. [The possibility of predicting the degree of plasmacyte reaction in response to administration of soluble antigen to mice].
    Levi MI; Sakaian NN; Livshits MM; Meshcheriakova IS; Rodionova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):104-12. PubMed ID: 235822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic kinetics and mathematical expression of the primary immune response to soluble antigen. VI. The possibility of prediction of plasma cell reaction in the spleen of mice immunized with soluble antigen.
    Levi MI; Sakayan NN; Livshits MM; Meschcheryakova IS
    Folia Microbiol (Praha); 1975; 20(4):354-64. PubMed ID: 1176044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid processing of material for the antibody neutralization test in case of detection of antigen of tularemia and F-1 plague].
    Dobrokhotov BP; Meshcheriakova IS
    Lab Delo; 1974; 7(9):440. PubMed ID: 4214964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cross immunity to plague and tularemia].
    Vasenin AS; Veĭnblat VI; Samoĭlova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):49-52. PubMed ID: 7395403
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous Immunodetection of Anthrax, Plague, and Tularemia from Blood Cultures by Use of Multiplexed Suspension Arrays.
    Mechaly A; Vitner E; Levy H; Weiss S; Bar-David E; Gur D; Koren M; Cohen H; Cohen O; Mamroud E; Fisher M
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Normal antibodies and immunologic reactivity].
    Levi MI; Selezneva TS; Livshits MM; Sakaian NN
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):81-7. PubMed ID: 986741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between the dose of soluble antigen and the plasmocytic reaction in regional lymph nodes during primary immunization (mathematical model)].
    Levi MI; Basova NN; Durikhin KV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Oct; 49(10):19-25. PubMed ID: 5083814
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic kinetics and mathematical expression of the primary immune response to soluble antigen. VII. The conveyer hypothesis and its mathematical expression.
    Levi MI; Smirnova OA
    Folia Microbiol (Praha); 1977; 22(2):117-27. PubMed ID: 557428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between calculated and empirical values for the count of cells forming antibodies to a soluble antigen].
    Levi MI; Livshits MM; Sakaian NN
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Mar; 50(3):114-22. PubMed ID: 4123080
    [No Abstract]   [Full Text] [Related]  

  • 10. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
    Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA
    Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenesis in White Mice Infected with Yersinia pestis with Different Plasmid Composition.
    Balakhonov SV; Vityazeva SA; Dubrovina VI; Starovoitova TP; Mukhturgin GB; Ivanova TA; Korytov KM; Kolesnikov SI
    Bull Exp Biol Med; 2017 Feb; 162(4):470-473. PubMed ID: 28243913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic kinetics and mathematical expression of the primary immune response to soluble antigen. I. Cyclic kinetics of immunogenesis.
    Levi MI; Dúrikhin KV; Basova NN; Shmúter LM; Suchkov YG; Lipnitskii AV; Gerasyuk LG
    Folia Microbiol (Praha); 1973; 18(3):229-36. PubMed ID: 4579241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of serotonin on immune competent cells of biomodels under the conditions of vaccination against plague and tularemia].
    Kliueva SN; Kravtsov AL; Shchukovskaia TN
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):32-8. PubMed ID: 25842950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the molecular weight of a soluble antigen on immunogenicity].
    Levi MI; Dalin MV; Nakoriakov VA; Livshits MM; Sakaian NN
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Dec; 50(12):77-83. PubMed ID: 4132082
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum antibody and splenocyte immunoglobulin receptor affinity in multiply immunized mice].
    Levi MI; Livshits MM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):80-5. PubMed ID: 6895274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of monoclonal antibodies for the production of a plague antibody erythrocyte diagnostic agent].
    Kanatov IuV; Levi MI; Shmuter MF; Men'shov PI; Temiralieva GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):73-8. PubMed ID: 3904286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.
    Goodin JL; Nellis DF; Powell BS; Vyas VV; Enama JT; Wang LC; Clark PK; Giardina SL; Adamovicz JJ; Michiel DF
    Protein Expr Purif; 2007 May; 53(1):63-79. PubMed ID: 17293124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.